Timing of Soft Tissue Grafting Following Immediate Implant Placement
Launched by UNIVERSITY GHENT · Sep 12, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the best timing for soft tissue grafting after placing an immediate dental implant in the front part of the mouth (the premaxilla). The goal is to understand whether performing the graft right after the implant surgery (called Immediate Soft Tissue Grafting) or waiting three months (called Delayed Soft Tissue Grafting) leads to better outcomes for preventing bone loss around the implant. Participants will have a small scan done before surgery to ensure they have enough healthy bone to support the implant and will then be randomly assigned to one of the two timing groups for the grafting procedure.
To qualify for this trial, you must be at least 20 years old, have good oral hygiene, and need to have a tooth removed in the front of your mouth, with a nearby healthy tooth still present. Other requirements include having enough bone for the implant and intact bone walls. If you join the study, you'll undergo the implant procedure, and depending on your assigned group, you'll receive the graft either immediately or three months later. Throughout the study, your progress will be monitored with follow-up scans one and five years after the procedure to check on bone health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • At least 20 years old
- • Good oral hygiene defined as full-mouth plaque score ≤ 25% (O'Leary et al. 1972)
- • Presence of an incisor, cuspid or premolar in the maxilla that needs to be extracted for any reason with at least one neighboring tooth present
- • At least 3 mm bone available at the apical or palatal aspect of the alveolus as assessed on CBCT to ensure primary implant stability
- • Intact buccal bone wall at the time of extraction
- • Written informed consent
- Exclusion Criteria:
- • Pregnancy
- • Systemic diseases
- • Smoking
- • Suppuration
- • \> 1 mm gingival asymmetry between the failing and contralateral tooth
- • Untreated periodontal disease; untreated caries lesions
About University Ghent
University Ghent is a prestigious Belgian research institution renowned for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a multidisciplinary approach, the university fosters collaboration among leading experts in various fields, ensuring rigorous study design and ethical standards. University Ghent is dedicated to exploring new therapeutic modalities and enhancing healthcare outcomes, making significant contributions to both local and global health landscapes. Its state-of-the-art facilities and emphasis on research excellence position it as a pivotal sponsor in the realm of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ghent, Oost Vlaanderen, Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials